Shah Rajeev M. 4
4 · Black Diamond Therapeutics, Inc. · Filed Apr 5, 2021
Insider Transaction Report
Form 4
Shah Rajeev M.
Director
Transactions
- Other
Common Stock
2021-04-01$24.26/sh+353,814$8,583,528→ 2,277,978 total(indirect: See Footnote)
Holdings
Common Stock
- (indirect: See Footnote)
Common Stock
Footnotes (5)
- [F1]On April 1, 2021, RA Capital Healthcare Fund, L.P. (the "Fund") acquired the reported shares as part of a reorganization of the assets of a separately managed account.
- [F2]Held directly by the Fund.
- [F3]Held directly by the Nexus Fund, L.P. (the "Nexus Fund").
- [F4]RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and the Nexus Fund. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.
- [F5]Under the Reporting Person's arrangement with RA Capital Management, L.P. (the "Adviser"), the Reporting Person holds the shares for the benefit of the RA Capital Healthcare Fund, L.P. (the "Fund"), RA Capital Nexus Fund, L.P. (the "Nexus Fund") and a separately managed account (the "Account"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received as compensation from the Issuer, which will offset advisory fees owed by the Fund, the Nexus Fund and the Account to the Adviser. The Reporting Person therefore disclaims beneficial ownership of the common stock.